2-Fluoro-5-(tributylstannyl)pyridine - CAS 1025687-41-5
Catalog: |
BB000890 |
Product Name: |
2-Fluoro-5-(tributylstannyl)pyridine |
CAS: |
1025687-41-5 |
Synonyms: |
tributyl-(6-fluoro-3-pyridinyl)stannane; tributyl-(6-fluoropyridin-3-yl)stannane |
IUPAC Name: | tributyl-(6-fluoropyridin-3-yl)stannane |
Description: | 2-Fluoro-5-(tributylstannyl)pyridine (CAS# 1025687-41-5) is a useful research chemical. |
Molecular Weight: | 386.14 |
Molecular Formula: | C17H30FNSn |
Canonical SMILES: | CCCC[Sn](CCCC)(CCCC)C1=CN=C(C=C1)F |
InChI: | InChI=1S/C5H3FN.3C4H9.Sn/c6-5-3-1-2-4-7-5;3*1-3-4-2;/h1,3-4H;3*1,3-4H2,2H3; |
InChI Key: | VLMHLVKGRNNZQF-UHFFFAOYSA-N |
Purity: | 96 % |
LogP: | 5.27680 |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]; H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H372 (100%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H410 (100%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard] |
Precautionary Statement: | P260, P264, P264+P265, P270, P273, P280, P301+P316, P302+P352, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
AU-2013307239-A1 | Diazepinone derivatives useful for the treatment of fragile X syndrome, Parkinsons or Reflux Disease | 20120823 |
AU-2013307239-B2 | Diazepinone derivatives useful for the treatment of fragile X syndrome, Parkinsons or Reflux Disease | 20120823 |
CA-2878564-A1 | Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease | 20120823 |
DK-2888259-T3 | Diazepinone derivatives suitable for the treatment of fragile X syndrome, Parkinson's or reflux disease | 20120823 |
EA-029493-B1 | DERIVATIVES OF DIAZEPINONA APPLICABLE FOR THE TREATMENT OF SYNDROME WITH Fragile X-CHROMOSOME, PARKINSON'S DISEASE OR REFLUX DISEASE | 20120823 |
Complexity: | 225 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 387.138431 |
Formal Charge: | 0 |
Heavy Atom Count: | 20 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 387.138431 |
Rotatable Bond Count: | 10 |
Topological Polar Surface Area: | 12.9 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS